Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.7900
+0.0390 (5.19%)
Dec 5, 2025, 4:00 PM EST - Market closed
MTNB Market Cap
MTNB has a market cap or net worth of $5.06 million as of December 5, 2025. Its market cap has increased by 74.51% in one year.
Market Cap
5.06M
Enterprise Value
1.96M
1-Year Change
74.51%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $5.06M, a decrease of -97.74%. That is a compound annual growth rate of -35.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.10M | 96.15% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |